- Cabazitaxel in the treatment of patients with metastatic castration-resistant prostate cancer2014 | First Faculty of Medicine
- Cabazitaxel v léčbě metastazujícího karcinomu prostaty2018 | First Faculty of Medicine
- Cabazitaxel in the treatment of a patient with prostate cancer2020 | Publication without faculty affiliation
- Cabazitaxel for the treatment of metastatic castration-resistant prostate cancer2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Topical Drug Delivery of Concentrated Cabazitaxel in an alpha-Tocopherol and DMSO Solution2023 | Faculty of Pharmacy in Hradec Králové
- Current treatment options for metastatic castration-resistant prostate cancer2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)2019 | Faculty of Medicine in Pilsen
- Komentář ke studii: Cabazitaxel a abirateron acetát po selhání docetaxelu v léčbě pacientů s metastazujícím kastračně rezistentním karcinomem prostaty2015 | Third Faculty of Medicine
- New hormonal agents in castration-resistant prostate cancer2013 | First Faculty of Medicine
- Docetaxel-Cabazitaxel-Enzalutamide Versus Docetaxel-Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer2017 | First Faculty of Medicine
- Možnosti léčby karcinomu prostaty po selhání docetaxelu2015 | First Faculty of Medicine
- Cytotoxic therapy of castration refractory prostate cancer2011 | First Faculty of Medicine
- Options of Chemotherapy in the Treatment of Prostate Cancer2017 | First Faculty of Medicine
- Radium-223 dichloride (Xofigo) - management of the treatment of castration-resistant prostate cancer2014 | Third Faculty of Medicine
- Strategies sequential treatment of metastatic castration-resistant prostate cancer2020 | First Faculty of Medicine
- ARTA treatment of metastatic castration-resistant prostate cancer - case report2021 | First Faculty of Medicine
- AR-V7 androgen receptor variant as a predictor of response to androgen-receptor targeting agents used to treat castration-refractory metastatic prostate cancer2018 | First Faculty of Medicine
- Prognostic factors in metastatic prostate cancer2023 | First Faculty of Medicine
